Aspen Pharmacare and MSD partner for innovative HIV prevention medicine
African News Agency | 24.07.2026 20:52
Aspen Pharmacare Holdings has reached a licensing agreement for a medicine still under formal approval process, that may provide a once-monthly, long-acting oral medicine to prevent HIV-1.
